In small cell lung cancer (SCLC, NCI-H209, and NCI-H146) and leukemic (Jurkat) cell lines, inhibition of K+ channels has also been implicated in upregulation of the p27kip1 protein and a reduction in cyclin. Here, CDKN1B is linked to small cell lung carcinoma.